South Korea braces for 'stroke tsunami' as aging population strains healthcare

South Korea is on the brink of a "stroke tsunami," with experts issuing a stark warning about the urgent need to establish a national acute stroke treatment safety net. As the country rapidly transitions into a super-aged society, with over 20% of its population aged 65 and above, the number of stroke patients is projected to surge dramatically.

Projections indicate that by 2050, the annual number of stroke cases could exceed 350,000, more than double the current rate. The estimated cost for acute care alone is expected to reach 9 trillion won. This escalating crisis threatens to overwhelm the existing medical infrastructure, which is struggling to keep pace with demographic shifts. The 대한신경과학회 (Korean Neurological Association) emphasized these concerns during a press conference held for "World Brain Day 2026," urging for innovation in the medical system to combat brain diseases in an aging society.

“

Even if there are available beds in the emergency room, there is a structural limitation where we cannot accept patients due to a shortage of neurology specialists dedicated to acute stroke treatment.

A critical issue highlighted by the association is the severe imbalance in the availability of stroke centers and specialists across different regions. Dr. Kim Tae-jung, a professor of neurology at Seoul National University Hospital and spokesperson for the Korean Stroke Society, pointed out that even when emergency room beds are available, many hospitals cannot accept stroke patients due to a lack of specialized neurology personnel. This structural limitation leads to frequent delays in patient transfers, jeopardizing the crucial "golden time" for treatment.

“

Improvement of health insurance coverage standards is necessary so that patients can immediately use oxygen at home at the onset of seizures.

To address this, the association proposed deploying dedicated neurology specialists within regional emergency medical centers. This would enable immediate initial diagnosis upon arrival at the ER and significantly reduce transfer times through real-time communication with emergency services like 119. Beyond stroke, the discussion also touched upon the precarious state of other neurological diseases. Essential medications for conditions like Parkinson's disease are facing delays in domestic introduction due to complex reimbursement evaluations and low pricing policies. Furthermore, emergency anti-seizure injection drugs, standard treatments for status epilepticus, have been discontinued due to low production costs.

The article also sheds light on systemic gaps affecting patients with conditions like cluster headaches, where recommended high-flow oxygen therapy is not covered by insurance, potentially exposing patients to industrial-grade oxygen. For Alzheimer's disease and other dementias, the focus is on creating a comprehensive treatment environment that combines new drug introductions with early diagnosis and functional preservation. The need for transitional home healthcare involving multidisciplinary teams immediately after hospital discharge for patients with severe neurological conditions, such as Lou Gehrig's disease and advanced Parkinson's, was also raised. Experts stressed the necessity of a tiered, hybrid payment structure that compensates for travel time and resource coordination to encourage medical professionals to provide care outside hospital settings.

“

A multi-layered hybrid payment structure that compensates for travel time and resource coordination must be introduced, and institutional decisions are needed to encourage medical professionals to design the remaining lives of patients.